TCI Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-138
| Closed | -$1.43K | – | 789 |
|
|
2023
Q1 | $1.43K | Sell |
138
-187
| -58% | -$2.26K | ﹤0.01% | 2045 |
|
|
2022
Q4 | $3.84K | Buy |
325
+322
| +10,733% | +$4.98K | ﹤0.01% | 1699 |
|
|
2022
Q3 | $0 | Sell |
3
-150
| -98% | -$4.17K | ﹤0.01% | 2322 |
|
|
2022
Q2 | $5K | Buy |
153
+18
| +13% | +$615 | ﹤0.01% | 1463 |
|
|
2022
Q1 | $5K | Sell |
135
-1
| -0.7% | -$44 | ﹤0.01% | 1521 |
|
|
2021
Q4 | $6K | Buy |
136
+102
| +300% | +$4.61K | ﹤0.01% | 1517 |
|
|
2021
Q3 | $2K | Sell |
34
-59
| -63% | -$3.57K | ﹤0.01% | 2107 |
|
|
2021
Q2 | $6K | Buy |
93
+3
| +3% | +$193 | ﹤0.01% | 1300 |
|
|
2021
Q1 | $8K | Buy |
90
+44
| +96% | +$4.51K | ﹤0.01% | 971 |
|
|
2020
Q4 | $4K | Hold |
46
| – | – | ﹤0.01% | 950 |
|
|
2020
Q3 | $5K | Hold |
46
| – | – | ﹤0.01% | 761 |
|
|
2020
Q2 | $4K | Hold |
46
| – | – | ﹤0.01% | 789 |
|
|
2020
Q1 | $3K | Buy |
46
+12
| +35% | +$692 | ﹤0.01% | 849 |
|
|
2019
Q4 | $2K | Hold |
34
| – | – | ﹤0.01% | 1128 |
|
|
2019
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 1063 |
|
|
2019
Q2 | $2K | Hold |
34
| – | – | ﹤0.01% | 998 |
|
|
2019
Q1 | $2K | Hold |
34
| – | – | ﹤0.01% | 1012 |
|
|
2018
Q4 | $2K | Hold |
34
| – | – | ﹤0.01% | 982 |
|
|
2018
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 1021 |
|
|
2018
Q2 | $2K | Hold |
34
| – | – | ﹤0.01% | 1058 |
|
|
2018
Q1 | $2K | Hold |
34
| – | – | ﹤0.01% | 958 |
|
|
2017
Q4 | $2K | Hold |
34
| – | – | ﹤0.01% | 1011 |
|
|
2017
Q3 | $1K | Hold |
34
| – | – | ﹤0.01% | 1093 |
|
|
2017
Q2 | $1K | Buy |
+34
| New | +$1.05K | ﹤0.01% | 1116 |
|
|
2016
Q3 | – | Sell |
-58
| Closed | -$2K | – | 1367 |
|
|
2016
Q2 | $2K | Hold |
58
| – | – | ﹤0.01% | 923 |
|
|
2016
Q1 | $2K | Buy |
+58
| New | +$2.05K | ﹤0.01% | 936 |
|
Other funds holding EBS
